重点产品
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 20510 | CC-92480 ( Mezigdomide ) | 2259648-80-9 | ≧98.0% |  |
| CC-92480 是一种有效的新型 CELMoD 化合物，旨在快速最大程度地降解 | ||||
| 24064 | Cirtuvivint ( SM08502 ) | 2143917-62-6 | ≧98.0% |  |
| Cirtuvivint是一种CDC样激酶（CLK）和双特异性酪氨酸磷酸化调节激酶 | ||||
| 24068 | Acoramidis hydrochloride | 2242751-53-5 | ≧98.0% |  |
| Acoramidis是一种口服、强效、高选择性小分子转甲状腺素蛋白（TTR | ||||
| 51703 | Luminespib ( NVP-AUY922 ; VER-52296 ) | 747412-49-3 | 98% | _747412-49-3.png) |
| NVP-AUY922 is an experimental drug candidate for the treatment of cancer. It was disc | ||||
| 51902 | AT13148 | 1056901-62-2 | ≧98% |  |
| AT13148, a first-in-class multi-AGC kinase inhibitor, against gastric cancer cells. A | ||||
| 51603 | AZD6482 | 1173900-33-8 | ≧98.0% |  |
| AZD6482 is aPI3Kinhibitor withIC50of 10 nM, 8-, 87- and 109-fold more selective to PI | ||||
| 51905 | CPI-613(Devimistat ) | 95809-78-2 | ≧98.0% |  |
| CPI-613( Devimistat ) is an E1 pyruvate dehydrogenase (PDH) modulator that prevents c | ||||
| 52023 | DCC-2036(Rebastinib) | 1020172-07-9 | 98% | _1020172-07-9.png) |
| Rebastinib(DCC-2036;DCC2036) is an inhibitor of tyrosine kinases TIE2 and ABL1.Rebast | ||||
| 52019 | GSK 2656157 | 1337532-29-2 | 98% |  |
| GSK2656157 is an ATP-competitive and highly selective inhibitor ofPERKwithIC50of 0.9 | ||||
| 51608 | SSR128129E | 848318-25-2 | 98% |  |
| SSR128129E is an orally-active and allostericFGFR1inhibitor withIC50of 1.9 M, while n | ||||
| 51607 | VE-822 ( Berzosertib ) | 1232416-25-9 | ≧98.0% |  |
| VE-822(Berzosertib), an analogue of VE-821 with increased potency and selectivity aga | ||||
| 52003 | Zosuquidar trihydrochloride | 167465-36-3 | 99% | _167465-36-3.png) |
| zosuquidar trihydrochloride is adifluorocyclopropyl quinoline. Zosuquidar trihydrochl | ||||